Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2021-04-15 Sale | 2021-04-16 8:46 pm | Jounce Therapeutics Inc. | JNCE | Higgons John Duncan Director | 200 | $10 | $2,000 | 9,713 (Direct) | View |
| 2021-03-15 Sale | 2021-03-17 9:15 pm | Jounce Therapeutics Inc. | JNCE | Higgons John Duncan Director | 200 | $12.8 | $2,560 | 9,913 (Direct) | View |
| 2021-02-16 Sale | 2021-02-18 7:47 pm | Jounce Therapeutics Inc. | JNCE | Higgons John Duncan Director | 200 | $11.78 | $2,356 | 10,113 (Direct) | View |
| 2021-01-20 Sale | 2021-01-22 6:39 pm | Jounce Therapeutics Inc. | JNCE | Higgons John Duncan Director | 1,700 | $11.9 | $20,222 | 10,313 (Direct) | View |
| 2020-01-06 Sale | 2020-01-08 4:56 pm | Jounce Therapeutics Inc. | JNCE | Higgons John Duncan Director | 1,500 | $8.11 | $12,165 | 12,013 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2022-06-24 Option Award | 2022-06-28 9:03 pm | N/A 2032-06-24 | Jounce Therapeutics Inc. | JNCE | Higgons John Duncan Director | 20,000 | $0 | 20,000 (Direct) | View |
| 2021-06-18 Option Award | 2021-06-22 4:46 pm | N/A 2031-06-18 | Jounce Therapeutics Inc. | JNCE | Higgons John Duncan Director | 15,700 | $0 | 15,700 (Direct) | View |
| 2020-06-26 Option Award(A) | 2020-07-02 7:34 pm | N/A 2030-06-26 | Jounce Therapeutics Inc. | JNCE | Higgons John Duncan Director | 15,700 | $0 | 15,700 (Direct) | View |
| 2020-06-26 Option Award | 2020-06-29 7:31 pm | N/A 2030-06-26 | Jounce Therapeutics Inc. | JNCE | Higgons John Duncan Director | 13,550 | $0 | 13,550 (Direct) | View |